Kunihara M, Ohyama M, Nakano M, Hayashi S
Dept. of Pharmacology, Upjohn Pharmaceuticals Limited Research Laboratory, Tsukuba, Japan.
Life Sci. 1989;45(13):1191-8. doi: 10.1016/0024-3205(89)90508-0.
The present study was undertaken to evaluate the analgesic potency of spiradoline mesylate, a k(kappa) opioid agonist, in comparison with that of morphine, by hot plate, tail-pinch and acetic acid-induced writhing assay. The ED50 values of spiradoline in hot plate, tail-pinch and acetic acid-induced writhing assay were 0.46, 0.26 and 0.20 mg/kg, respectively. The analgesic potency of spiradoline was 1.5-7.0 times higher than that of morphine. Repeated treatment with spiradoline as well as morphine developed tolerance to the analgesic effect in hot plate assay. In mice developed tolerance to one analgesic, response to the other analgesic did not alter compared to saline-treated mice. Single administration of spiradoline (1.5 and 3 mg/kg, s.c.) did not inhibit morphine-induced analgesia. These results suggest that spiradoline has more potent analgesic activity than morphine, presumably mediated through stimulation of receptors different from morphine.
本研究旨在通过热板法、尾夹法和醋酸诱导扭体试验,评估κ阿片受体激动剂甲磺酸螺旋多林与吗啡相比的镇痛效力。甲磺酸螺旋多林在热板法、尾夹法和醋酸诱导扭体试验中的半数有效量(ED50)分别为0.46、0.26和0.20mg/kg。甲磺酸螺旋多林的镇痛效力比吗啡高1.5至7.0倍。在热板试验中,重复给予甲磺酸螺旋多林以及吗啡均会产生镇痛耐受。在对一种镇痛药产生耐受的小鼠中,与生理盐水处理的小鼠相比,对另一种镇痛药的反应没有改变。单次给予甲磺酸螺旋多林(1.5和3mg/kg,皮下注射)不会抑制吗啡诱导的镇痛作用。这些结果表明,甲磺酸螺旋多林具有比吗啡更强的镇痛活性,可能是通过刺激与吗啡不同的受体介导的。